Impact of inflammatory biomarkers on relation of high density lipoprotein-cholesterol with incident coronary heart disease: Cardiovascular Health Study

被引:66
作者
Tehrani, David M. [1 ]
Gardin, Julius M. [2 ]
Yanez, David [3 ]
Hirsch, Calvin H. [4 ]
Lloyd-Jones, Donald M. [5 ]
Stein, Phyllis K. [6 ]
Wong, Nathan D. [1 ]
机构
[1] Univ Calif Irvine, Heart Dis Prevent Program, Div Cardiol, Sch Med, Irvine, CA 92697 USA
[2] Hackensack Univ, Med Ctr, Div Cardiol, Hackensack, NJ USA
[3] Univ Washington, Sch Med, Dept Biostat, Seattle, WA USA
[4] Univ Calif Davis, Sch Med, Div Gen Internal Med, Davis, CA 95616 USA
[5] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA
[6] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
关键词
High density lipoprotein; Inflammation; C-reactive protein; Coronary heart disease; C-REACTIVE PROTEIN; PHOSPHOLIPASE A(2); STATIN THERAPY; RISK; ASSOCIATION; ADULTS; HDL; INTERLEUKIN-6; ATORVASTATIN; TORCETRAPIB;
D O I
10.1016/j.atherosclerosis.2013.08.036
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Background: Inflammatory factors and low HDL-C relate to CHD risk, but whether inflammation attenuates any protective association of high HDL-C is unknown. Objective: Investigate inflammatory markers' individual and collective impact on the association of HDLC with incident coronary heart disease (CHD). Methods: In 3888 older adults without known cardiovascular disease (CVD), we examined if the inflammatory markers C-reactive protein (CRP), interleukin-6 (IL-6), and lipoprotein-associated phospholipase A(2)(Lp-PLA(2)) modify the relation of HDL-C with CHD. HDL-C, CRP, IL-6, and Lp-PLA(2) values were grouped as using gender-specific tertiles. Also, an inflammation index of z-score sums for CRP, IL-6, and Lp-PLA(2) was categorized into tertiles. We calculated CHD incidence for each HDL-C/inflammation group and performed Cox regression, adjusted for standard CVD risk factors and triglycerides to examine the relationship of combined HDL-C-inflammation groups with incident events. Results: CHD incidence (per 1000 person years) was higher for higher levels of CRP, IL-6, and the index, and lower for higher levels of HDL-C. Compared to high HDL-C/low-inflammation categories (referent), adjusted HRs for incident CHD were increased for those with high HDL-C and high CRP (HR 1.50, p < 0.01) or highest IL-6 tertile (HR 1.40, p < 0.05), but not with highest Lp-PLA(2) tertile. Higher CHD incidence was similarly seen for those with intermediate or low HDL-C accompanied by high CRP, high IL-6, or a high inflammatory index. Conclusion: The protective relation of high HDL-C for incident CHD appears to be attenuated by greater inflammation. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:246 / 251
页数:6
相关论文
共 32 条
[1]
Changes in total and high-density lipoprotein cholesterol over 10- and 20-year periods (the Honolulu Heart Program) [J].
Abbott, RD ;
Yano, K ;
Hakim, AA ;
Burchfiel, CM ;
Sharp, DS ;
Rodriguez, BL ;
Curb, JD .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (02) :172-178
[2]
[Anonymous], 2001, JAMA-J AM MED ASSOC
[3]
The paradox of dysfunctional high-density lipoprotein [J].
Ansell, Benjamin J. ;
Fonarow, Gregg C. ;
Fogelman, Alan M. .
CURRENT OPINION IN LIPIDOLOGY, 2007, 18 (04) :427-434
[4]
Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment [J].
Ansell, BJ ;
Navab, M ;
Hama, S ;
Kamranpour, N ;
Fonarow, G ;
Hough, G ;
Rahmani, S ;
Mottahedeh, R ;
Dave, R ;
Reddy, ST ;
Fogelman, AM .
CIRCULATION, 2003, 108 (22) :2751-2756
[5]
Effects of torcetrapib in patients at high risk for coronary events [J].
Barter, Philip J. ;
Caulfield, Mark ;
Eriksson, Mats ;
Grundy, Scott M. ;
Kastelein, John J. P. ;
Komajda, Michel ;
Lopez-Sendon, Jose ;
Mosca, Lori ;
Tardif, Jean-Claude ;
Waters, David D. ;
Shear, Charles L. ;
Revkin, James H. ;
Buhr, Kevin A. ;
Fisher, Marian R. ;
Tall, Alan R. ;
Brewer, Bryan .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21) :2109-2122
[6]
High-sensitivity C-reactive protein: Clinical importance [J].
Bassuk, SS ;
Rifai, N ;
Ridker, PM .
CURRENT PROBLEMS IN CARDIOLOGY, 2004, 29 (08) :439-493
[7]
High-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Cardiovascular. Disease in United States Adults [J].
Bilhorn, Kyle R. ;
Luo, Yanting ;
Lee, Brian T. ;
Wong, Nathan D. .
AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (10) :1464-1467
[8]
Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy [J].
Boden, William E. ;
Probstfield, Jeffrey L. ;
Anderson, Todd ;
Chaitman, Bernard R. ;
Desvignes-Nickens, Patrice ;
Koprowicz, Kent ;
McBride, Ruth ;
Teo, Koon ;
Weintraub, William .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (24) :2255-2267
[9]
Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis [J].
Briel, Matthias ;
Ferreira-Gonzalez, Ignacio ;
You, John J. ;
Karanicolas, Paul J. ;
Akl, Elie A. ;
Wu, Ping ;
Blechacz, Boris ;
Bassler, Dirk ;
Wei, Xinge ;
Sharman, Asheer ;
Whitt, Irene ;
da Silva, Suzana Alves ;
Khalid, Zahira ;
Nordmann, Alain J. ;
Zhou, Qi ;
Walter, Stephen D. ;
Vale, Noah ;
Bhatnagar, Neera ;
O'Regan, Christopher ;
Mills, Edward J. ;
Bucher, Heiner C. ;
Montori, Victor M. ;
Guyatt, Gordon H. .
BMJ-BRITISH MEDICAL JOURNAL, 2009, 338
[10]
INCIDENCE OF CORONARY HEART-DISEASE AND LIPOPROTEIN CHOLESTEROL LEVELS - THE FRAMINGHAM-STUDY [J].
CASTELLI, WP ;
GARRISON, RJ ;
WILSON, PWF ;
ABBOTT, RD ;
KALOUSDIAN, S ;
KANNEL, WB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20) :2835-2838